Bone Biologics Corp Warrants (BBLGW)
Company Info
| Sector | Healthcare |
|---|---|
| Industry | Medical Devices |
Highlights
| EPS | -$0.14 |
|---|---|
| Year Range | $0.02 - $25.01 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Bone Biologics Corp Warrants, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Bone Biologics Corp Warrants had a return of 506.89% year-to-date (YTD) and 79,200.00% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 506.89% | 7.50% |
| 1 month | 116.27% | -1.61% |
| 6 months | 971.62% | 17.65% |
| 1 year | 79,200.00% | 26.26% |
| 5 years (annualized) | N/A | 11.73% |
| 10 years (annualized) | N/A | 10.64% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 282.40% | -59.24% | 181.51% | 38.95% | ||||||||
| 2023 | -81.98% | -63.60% | 330.77% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of BBLGW is 100, placing it in the top 0% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Bone Biologics Corp Warrants(BBLGW)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Bone Biologics Corp Warrants (BBLGW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Bone Biologics Corp Warrants. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Bone Biologics Corp Warrants was 98.57%, occurring on Dec 20, 2022. Recovery took 125 trading sessions.
The current Bone Biologics Corp Warrants drawdown is 4.88%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.57% | Nov 3, 2021 | 285 | Dec 20, 2022 | 125 | Jun 22, 2023 | 410 |
| -96.92% | Sep 21, 2023 | 61 | Dec 15, 2023 | 84 | Apr 18, 2024 | 145 |
| -50% | Jun 26, 2023 | 8 | Jul 6, 2023 | 36 | Aug 25, 2023 | 44 |
| -27.9% | Oct 14, 2021 | 9 | Oct 26, 2021 | 4 | Nov 1, 2021 | 13 |
| -18.37% | Aug 31, 2023 | 1 | Aug 31, 2023 | 2 | Sep 5, 2023 | 3 |
Volatility
Volatility Chart
The current Bone Biologics Corp Warrants volatility is 56.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |